✦ LIBER ✦

Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil

✍ Scribed by Kabei, Kazuya; Uchida, Junji; Iwai, Tomoaki; Yamasaki, Takeshi; Kuwabara, Nobuyuki; Naganuma, Toshihide; Kumada, Norihiko; Nakatani, Tatsuya

Book ID: 125857459
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 386 KB
Volume: 31
Category: Article
ISSN: 0966-3274
DOI: 10.1016/j.trim.2014.06.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mycophenolate Mofetil Use Is Associated

Mycophenolate Mofetil Use Is Associated with Decreased Risk of Late Acute Rejection in Adult Liver Transplant Recipients

✍ R. H. Wiesner; B. J. Steffen; K. M. David; A. H. Chu; R. D. Gordon; J. R. Lake 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Basiliximab and Mycophenolate Mofetil in

Basiliximab and Mycophenolate Mofetil in Combination With Low-Dose Cyclosporine and Methylprednisolone Effectively Prevent Acute Rejection in Kidney Transplant Recipients

✍ D. Kovac; V. Kotnik; A. Kandus 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Mycophenolate mofetil vs. azathioprine i

Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes

✍ Kristin M David; Jonathan A Morris; Bettina J Steffen; Kathy S Chi-Burris; Vince 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB